Fact check
“The FDA’s filing review phase typically takes longer than the acceptance review.”
Reasoning
The provided evidence includes statements that the acceptance phase can exceed statutory deadlines and that the subsequent filing review "typically takes even longer than 'acceptance' review," directly supporting the claim that the filing review phase is usually longer.
On confidence: Two independent excerpts from the same Reason.com article explicitly state that the filing review phase typically takes longer than the acceptance review.
Important context
The evidence pertains to FDA review timelines for nicotine product applications under the 2021 Final Rule, citing specific case examples and plaintiff arguments.
Evidence
Supporting (2)
- Tier 3 — Secondary reportingThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
requirements,'" Helix et al. note. The FDA's forms "sometimes lack the requisite fields for all products," they say, which causes the FDA to refuse acceptance for "purely administrative reasons." By itself, the "acceptance" phase "often…
- Tier 3 — Secondary reportingThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
determine whether it contains "sufficient information to permit a full substantive review." That phase, Helix et al. say, "typically takes even longer than 'acceptance' review." And even after "an application had been accepted and filed,"…
Limitations
Both excerpts come from a single secondary reporting source; no primary FDA documentation is provided to corroborate the typical duration across all product categories. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:41 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
The FDA Promises To Streamline the Dauntingly Complex Rules for Approving Nicotine ProductsReason · Jacob Sullum